← FDA DRUG APPROVALS

FDA NDA · NDA018985

ORTHO-NOVUM 7/7/7-28

Sponsor: JANSSEN PHARMS

APPLICATION
NDA018985
TYPE
NDA
ORIGINAL APPROVAL
1984-04-04
LATEST ACTION
2017-08-09
ROUTE
ORAL-28, ORAL-21
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ORTHO-NOVUM 7/7/7-28 · ReferenceDiscontinued
ETHINYL ESTRADIOL 0.035MG,0.035MG,0.035MG, NORETHINDRONE 0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET · ORAL-28
ORTHO-NOVUM 7/7/7-21Discontinued
ETHINYL ESTRADIOL 0.035MG,0.035MG,0.035MG, NORETHINDRONE 0.5MG,0.75MG,1MG · TABLET · ORAL-21

Approval history

2017-08-09Labeling · Supplement 64 · standardLabelAP
2015-10-29Labeling · Supplement 63 · standardLabelAP
2014-09-11Manufacturing (CMC) · Supplement 62 · standardAP
2013-10-03Labeling · Supplement 50 · standardLetterAP
2013-10-02Labeling · Supplement 60 · standardLetterAP
2013-10-02Labeling · Supplement 56 · standardLetterAP
2013-10-02Labeling · Supplement 54 · standardLetterAP
2012-06-18Labeling · Supplement 53 · standardLabelAP
2002-06-03Manufacturing (CMC) · Supplement 39 · standardAP
2002-02-21Manufacturing (CMC) · Supplement 38 · standardAP
2001-07-09Manufacturing (CMC) · Supplement 37 · standardAP
2000-06-06Labeling · Supplement 35 · standardAP
2000-01-05Manufacturing (CMC) · Supplement 34 · standardAP
1999-08-27Labeling · Supplement 30 · standardAP
1999-08-27Labeling · Supplement 29 · standardAP
1999-08-27Labeling · Supplement 33 · standardAP
1998-04-28Manufacturing (CMC) · Supplement 32 · standardAP
1998-04-13Manufacturing (CMC) · Supplement 31 · standardAP
1997-02-24Manufacturing (CMC) · Supplement 28 · standardAP
1997-01-29Manufacturing (CMC) · Supplement 27 · standardAP
1996-05-10Manufacturing (CMC) · Supplement 25 · standardAP
1996-04-09Manufacturing (CMC) · Supplement 26 · standardAP
1995-11-30Manufacturing (CMC) · Supplement 24 · standardAP
1995-09-07Manufacturing (CMC) · Supplement 23 · standardAP
1995-02-16Manufacturing (CMC) · Supplement 22 · standardAP
1994-03-07Manufacturing (CMC) · Supplement 17 · standardAP
1994-01-03Labeling · Supplement 20 · standardAP
1993-11-04Manufacturing (CMC) · Supplement 21 · standardAP
1993-05-18Manufacturing (CMC) · Supplement 19 · standardAP
1991-09-16Labeling · Supplement 14AP
1991-03-18Manufacturing (CMC) · Supplement 15 · standardAP
1990-01-18Manufacturing (CMC) · Supplement 13 · standardAP
1989-10-23Labeling · Supplement 11AP
1989-07-19Labeling · Supplement 10AP
1988-10-28Manufacturing (CMC) · Supplement 9 · standardAP
1988-09-09Labeling · Supplement 7AP
1988-06-08Manufacturing (CMC) · Supplement 8 · standardAP
1987-11-23Manufacturing (CMC) · Supplement 5 · standardAP
1987-02-02Labeling · Supplement 6AP
1985-10-21Labeling · Supplement 3AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →